We have made a number of prototype dermatological products to illustrate the key advantages of using our PAD technology as a formulation platform. Such prototype products include combinations of calcipotriene and corticosteroids (betamethasone, clobetasol or fluticasone proprionate) for psoriasis.

PAD technology allows us to work with different pH values in the final formulation and to lower the amount of surfactant and preservatives needed thereby broadening the scope of the formulations.

We are working on reformulating existing, off-patent API's as well as formulating NCE's in collaboration with partners.